Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using theemail support widget if the problem persists.
The following section summarizes insights on Esperion Therapeutics Inc's Total Debt:
We've identified the following companies as similar to Esperion Therapeutics Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Total Debt in the popular category include:
The sum of all debt and capital lease obligations.
Esperion Therapeutics reported total debt of 591.2 M for the latest quarter ending December 31, 2024 on its balance sheet.
The tables below summarizes Esperion Therapeutics’s Total Debt and common size over the last five years:
| Fiscal Year | Total Debt | Assets | % Assets |
|---|---|---|---|
| 2020-12-31 | 362 M | 353.3 M | 102.5% |
| 2021-12-31 | 517.2 M | 381.6 M | 135.5% |
| 2022-12-31 | 504.6 M | 247.9 M | 203.5% |
| 2023-12-31 | 540.9 M | 205.8 M | 262.9% |
| 2024-12-31 | 591.2 M | 343.8 M | 172.0% |
The tables below summarizes Esperion Therapeutics’s Total Debt and common size over the last four quarters:
| Quarter Ending | Total Debt | Assets | % Assets |
|---|---|---|---|
| 2024-03-31 | 548.9 M | 373.1 M | 147.1% |
| 2024-06-30 | 556.6 M | 352.3 M | 158.0% |
| 2024-09-30 | 559.6 M | 314.1 M | 178.1% |
| 2024-12-31 | 591.2 M | 343.8 M | 172.0% |